Robertson D A, Aldersley M A, Shepherd H, Lloyd R S, Smith C L
Department of Medicine II, Southhampton General Hospital.
Gut. 1987 Aug;28(8):946-9. doi: 10.1136/gut.28.8.946.
Ambulatory oesophageal pH, oesophageal manometry and fasting serum gastrin concentrations were carried out on 28 patients with reflux oesophagitis, before and during treatment with ranitidine 300 mg bd. Fourteen patients healed endoscopically at six weeks (group A) and 14 had residual oesophagitis (group B). Group A were characterised by a lower serum gastrin concentration before treatment (4.52 pmol/l; 2.4-10: mean and range) than group B (11.1 pmol/l; 3.5-21: p less than 0.05) and showed a marked reduction in acid reflux on treatment to near normal values. Mean per cent time below pH4 fell from 14.9 to 4.2 in group A (p less than 0.05) but was not affected in group B (14.2-15.6, not significant). Abnormal oesophageal motility was found in 13 patients from each group. This did not inhibit the response to ranitidine, and was not improved by healing of oesophagitis.
对28例反流性食管炎患者在服用雷尼替丁300毫克每日两次治疗前及治疗期间进行了动态食管pH监测、食管测压和空腹血清胃泌素浓度检测。14例患者在六周时内镜检查愈合(A组),14例有残余食管炎(B组)。A组的特征是治疗前血清胃泌素浓度(4.52皮摩尔/升;2.4 - 10:均值和范围)低于B组(11.1皮摩尔/升;3.5 - 21:p小于0.05),且治疗后酸反流明显减少至接近正常水平。A组pH值低于4的平均时间百分比从14.9降至4.2(p小于0.05),但B组未受影响(14.2 - 15.6,无显著性差异)。每组各有13例患者存在食管动力异常。这并未抑制对雷尼替丁的反应,食管炎愈合后也未改善。